Randy Hughes is co-chair of the firm's competition and antitrust practice, and is widely acknowledged as one of Canada's leading competition lawyers. Randy is recognized nationally and internationally in Chambers Global, the International Who's Who of Competition Lawyers, Lexpert/The American Lawyer Guide to the Leading 500 Lawyers in Canada, the Canadian Legal Lexpert Directory, the Competition Cross-border Handbook, the International Who's Who of Business Lawyers, the Guide to the World's Leading Competition and Antitrust Lawyers, and the Best of the Best (Competition and Antitrust Lawyers).
Randy has successfully handled the competition law and Investment Canada aspects of numerous domestic and international mergers and acquisitions and represented clients before the courts in criminal proceedings under the Competition Act and before the Competition Tribunal in reviewable matters.
Randy represents clients in domestic and international conspiracy investigations and prosecutions involving the Competition Bureau in Canada and other competition authorities around the world. He also represents clients in substantial civil actions, including leading class actions, by those claiming damages as a result of anticompetitive conduct. Randy has acted as counsel for the Commissioner of Competition and for private sector clients in leading merger and abuse of dominance cases before the Competition Tribunal.
Randy has served as Canadian non-governmental advisor (NGA) at the International Competition Network (ICN) of enforcement agencies Cartel Workshops and Annual Conferences, on the faculty of the ABA/IBA International Cartel Workshops and as a member of the ABA Antitrust Section International Cartel Task Force. He is currently Vice Chair of the Section's Cartel and Criminal Practice Committee and an Officer of the IBA Antitrust Committee.
Randy also represents clients in other regulatory matters before a variety of courts and tribunals. In particular, he acted as counsel in the Commission of Inquiry into the Use of Drugs and Banned Products Intended to Increase Athletic Performance (the Dubin Inquiry) and the Commission of Inquiry on the Blood System in Canada (the Krever Inquiry), where he appeared before the Supreme Court of Canada.